RTW Investments’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

RTW Investments’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,382,199	Closed	-$72.3M	–	123
2021 Q1	$72.3M	Buy	4,382,199 +1,403,772	+47%	+$32M	1.13%	31
2020 Q4	$54.9M	Sell	2,978,427 -766,859	-20%	-$13.7M	0.92%	32
2020 Q3	$51M	Buy	3,745,286 +28,292	+0.8%	+$436K	1.23%	25
2020 Q2	$66.6M	Buy	3,716,994 +24,570	+0.7%	+$370K	1.87%	16
2020 Q1	$36.8M	Buy	3,692,424 +387,616	+12%	+$3.18M	1.58%	20
2019 Q4	$26.9M	Buy	3,304,808 +156,180	+5%	+$1.44M	1.02%	27
2019 Q3	$31.2M	Buy	3,148,628 +709,378	+29%	+$6.7M	1.86%	19
2019 Q2	$30.8M	Buy	2,439,250 +1,086,280	+80%	+$11.5M	1.65%	18
2019 Q1	$13.8M	Buy	+1,352,970	New	+$10.4M	0.94%	29

Other funds holding TBIO

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AVA

Atlas Venture Advisors Boston, Massachusetts $143M AUM 25.68% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

RTW Investments's TBIO Position: Q2 2021 in Review

RTW Investments sold out of Translate Bio, Inc. Common Stock (TBIO) in Q2 2021, closing a stake of 4,382,199 shares — an estimated $72.3M sold.

RTW Investments first reported a position in TBIO in Q1 2019 and held it in 9 quarters. The position peaked at $72.3M in Q1 2021. 145 funds tracked by Wall St. Rank hold TBIO as of Q2 2021.

RTW Investments reported no remaining Translate Bio, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
RTW Investments sold 4,382,199 Translate Bio, Inc. Common Stock shares in Q2 2021, an estimated $72.3M.
RTW Investments first reported a position in Translate Bio, Inc. Common Stock in Q1 2019 and held it in 9 quarters.
RTW Investments's Translate Bio, Inc. Common Stock position peaked at $72.3M in Q1 2021.
145 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q2 2021.

Based on RTW Investments's 13F filing for Q2 2021, filed 13 Aug 2021.